Assignee
VIIV HEALTHCARE CO
US·19 granted patents·40 pending applications·11 citations·filing 2013–2025
Top patents by PatentIndex Score
59 records- 0192US12178815B2Regimens for treating HIV infections and aidsVIIV HEALTHCARE CO·Filed 2024·Granted Dec 31, 2024·3 cites·30 claims
- 0287US11564921B2Regimens for treating HIV infections and AIDSVIIV HEALTHCARE CO·Filed 2018·Granted Jan 31, 2023·4 cites·23 claims
- 0384US11117904B2Compositions and methods for the delivery of therapeuticsVIIV HEALTHCARE CO·Filed 2017·Granted Sep 14, 2021·2 cites·28 claims
- 0483US12138264B2Pharmaceutical compositionsVIIV HEALTHCARE CO·Filed 2024·Granted Nov 12, 2024·0 cites·30 claims
- 0582US2025017923A1Pharmaceutical compositionsVIIV HEALTHCARE CO·Filed 2024·Application pending·0 cites
- 0682US2025017939A1Antiviral TherapyVIIV HEALTHCARE CO·Filed 2024·Application pending·0 cites
- 0782US2025017924A1Pharmaceutical compositionsVIIV HEALTHCARE CO·Filed 2024·Application pending·0 cites
- 0881US2025114352A1Regimens for treating hiv infections and aidsVIIV HEALTHCARE CO·Filed 2024·Application pending·0 cites
- 0977US11234985B2Antiviral therapyVIIV HEALTHCARE CO·Filed 2020·Granted Feb 1, 2022·1 cites·16 claims
- 1077US2022096469A1Pharmaceutical compositionsVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 1176US2025268893A1Pharmaceutical compositionsVIIV HEALTHCARE CO·Filed 2025·Application pending·0 cites
- 1274US2023120910A1Regimens for treating hiv infections and aidsVIIV HEALTHCARE CO·Filed 2022·Application pending·0 cites
- 1372US8765965B21-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid of the formula P-6 and/or methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate of the formula P-7VIIV HEALTHCARE CO·Filed 2013·Granted Jul 1, 2014·0 cites·2 claims
- 1471US10426780B2Antiviral therapyVIIV HEALTHCARE CO·Filed 2016·Granted Oct 1, 2019·1 cites·17 claims
- 1571US2021401850A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 1669US10654870B2Process for preparing substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivativesVIIV HEALTHCARE CO·Filed 2018·Granted May 19, 2020·0 cites·2 claims
- 1769US10654871B2Process for preparing (3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamideVIIV HEALTHCARE CO·Filed 2018·Granted May 19, 2020·0 cites·3 claims
- 1869US10647728B2Process for preparing (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-Hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acidVIIV HEALTHCARE CO·Filed 2018·Granted May 12, 2020·0 cites·1 claims
- 1969US9120817B2Process for preparing (4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′ ,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acidVIIV HEALTHCARE CO·Filed 2014·Granted Sep 1, 2015·0 cites·1 claims
- 2069US2025302829A1Method for treating hiv with cabotegravir and rilpivirineVIIV HEALTHCARE CO·Filed 2025·Application pending·0 cites
- 2169US2025302830A1Method for treating hiv with cabotegravir and rilpivirineVIIV HEALTHCARE CO·Filed 2025·Application pending·0 cites
- 2267US8940912B24-oxo-3-[(phenylmethyl)oxy]-4H-pyran-2-carboxylic acidVIIV HEALTHCARE CO·Filed 2013·Granted Jan 27, 2015·0 cites·1 claims
- 2366US10233196B2Process for preparing substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivativesVIIV HEALTHCARE CO·Filed 2018·Granted Mar 19, 2019·0 cites·1 claims
- 2466US10174051B2Substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivativesVIIV HEALTHCARE CO·Filed 2018·Granted Jan 8, 2019·0 cites·2 claims
- 2564US9938296B2Process for preparing (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamideVIIV HEALTHCARE CO·Filed 2017·Granted Apr 10, 2018·0 cites·2 claims
- 2663US2025326771A1Piperazine derivatives useful in hiv therapyVIIV HEALTHCARE CO·Filed 2023·Application pending·0 cites
- 2762US2025034607A1Process of Synthesizing (R)-3-aminobutan-1-olVIIV HEALTHCARE CO·Filed 2022·Application pending·0 cites
- 2861US9643981B2Process for preparing (4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamideVIIV HEALTHCARE CO·Filed 2015·Granted May 9, 2017·0 cites·1 claims
- 2960US2018200254A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2018·Application pending·0 cites
- 3059US2018098992A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2017·Application pending·0 cites
- 3159US2024425568A1Combination therapies for hiv infections and uses thereofVIIV HEALTHCARE CO·Filed 2022·Application pending·0 cites
- 3259US2024182510A1Compounds Useful in HIV TreatmentVIIV HEALTHCARE CO·Filed 2022·Application pending·0 cites
- 3358US2017281636A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2017·Application pending·0 cites
- 3458US2025296988A1Combination therapyVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 3558US2024091159A1Combination and Uses and Treatments ThereofVIIV HEALTHCARE CO·Filed 2023·Application pending·0 cites
- 3657US11224597B2Pharmaceutical compositionsVIIV HEALTHCARE CO·Filed 2016·Granted Jan 18, 2022·0 cites·12 claims
- 3757US2017216284A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2017·Application pending·0 cites
- 3857US2022347174A1Method for treating HIV with Cabotegravir and RilpivirineVIIV HEALTHCARE CO·Filed 2020·Application pending·0 cites
- 3956US2023233470A1FormulationsVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 4055US2023285307A1Dispersible Tablet Formulations Comprising DolutegravirVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 4155US2016339033A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2016·Application pending·0 cites
- 4254US2023151049A1Compounds Useful in HIV TherapyVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 4354US2016199379A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2016·Application pending·0 cites
- 4453US2023226050A1Method of achieving hiv viral remission using long-acting antiretroviral agentsVIIV HEALTHCARE CO·Filed 2021·Application pending·0 cites
- 4552US2015238496A1Antiviral therapyVIIV HEALTHCARE CO·Filed 2015·Application pending·0 cites
- 4652US2022370466A1Regimens for treating hiv infections and aidsVIIV HEALTHCARE CO·Filed 2022·Application pending·0 cites
- 4751US10758531B2Regimens and compositions for treating HIV infections and AIDSVIIV HEALTHCARE CO·Filed 2017·Granted Sep 1, 2020·0 cites·12 claims
- 4851US2022096487A1Methods for treating hiv with dolutegravir and lamivudineVIIV HEALTHCARE CO·Filed 2020·Application pending·0 cites
- 4950US2025262163A1Combination and Uses and Treatments ThereofVIIV HEALTHCARE CO·Filed 2025·Application pending·0 cites
- 5047US2019183901A1Combinations and uses and treatments thereofVIIV HEALTHCARE CO·Filed 2017·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VIIV HEALTHCARE CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →